{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T13:11:51Z","timestamp":1793797911343,"version":"4.6.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.biomaterials.2023.122232","type":"journal-article","created":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T02:27:28Z","timestamp":1688005648000},"page":"122232","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"special_numbering":"C","title":["Dually fibronectin\/CD44-mediated nanoparticles targeted disrupt the Golgi apparatus and inhibit the hedgehog signaling in activated hepatic stellate cells to alleviate liver fibrosis"],"prefix":"10.1016","volume":"301","author":[{"given":"Yanping","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinhui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyi","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenfei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimin","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3410-8602","authenticated-orcid":false,"given":"Yuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6487-4696","authenticated-orcid":false,"given":"Jinhan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.biomaterials.2023.122232_bib1","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","article-title":"Molecular and cellular mechanisms of liver fibrosis and its regression","volume":"18","author":"Kisseleva","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.biomaterials.2023.122232_bib2","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nri3623","article-title":"Liver fibrosis and repair: immune regulation of wound healing in a solid organ","volume":"14","author":"Pellicoro","year":"2014","journal-title":"Nat. Rev. Immunol."},{"issue":"17","key":"10.1016\/j.biomaterials.2023.122232_bib3","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1056\/NEJMoa2029349","article-title":"Prospective study of outcomes in adults with nonalcoholic fatty liver disease","volume":"385","author":"Sanyal","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"24","key":"10.1016\/j.biomaterials.2023.122232_bib4","doi-asserted-by":"crossref","first-page":"9448","DOI":"10.1073\/pnas.1201840109","article-title":"Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis","volume":"109","author":"Kisseleva","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.biomaterials.2023.122232_bib5","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.bpg.2017.04.005","article-title":"Reversal of liver fibrosis: from fiction to reality","volume":"31","author":"Zoubek","year":"2017","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"10.1016\/j.biomaterials.2023.122232_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104720","article-title":"Intercellular crosstalk of hepatic stellate cells in liver fibrosis: new insights into therapy","volume":"155","author":"Cai","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"3","key":"10.1016\/j.biomaterials.2023.122232_bib7","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/hep.28948","article-title":"The origin of fibrogenic myofibroblasts in fibrotic liver","volume":"65","author":"Kisseleva","year":"2017","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.biomaterials.2023.122232_bib8","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"10","key":"10.1016\/j.biomaterials.2023.122232_bib9","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s12272-022-01408-z","article-title":"New insights into the role of the Golgi apparatus in the pathogenesis and therapeutics of human diseases","volume":"45","author":"Choi","year":"2022","journal-title":"Arch Pharm. Res. (Seoul)"},{"issue":"2","key":"10.1016\/j.biomaterials.2023.122232_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/biom11020205","article-title":"Deoxycholic acid upregulates serum Golgi protein 73 through activating NF-\u03baB pathway and destroying Golgi structure in liver disease","volume":"11","author":"Yang","year":"2021","journal-title":"Biomolecules"},{"issue":"8","key":"10.1016\/j.biomaterials.2023.122232_bib11","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/tra.12493","article-title":"Cell survival and protein secretion associated with Golgi integrity in response to Golgi stress-inducing agents","volume":"18","author":"Ignashkova","year":"2017","journal-title":"Traffic"},{"issue":"11","key":"10.1016\/j.biomaterials.2023.122232_bib12","doi-asserted-by":"crossref","first-page":"18430","DOI":"10.1021\/acsnano.2c06584","article-title":"Engineered platelet microparticle-membrane camouflaged nanoparticles for targeting the Golgi apparatus of synovial fibroblasts to attenuate rheumatoid arthritis","volume":"16","author":"Deng","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2023.122232_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2020.116887","article-title":"Chondroitin-modified lipid nanoparticles target the Golgi to degrade extracellular matrix for liver cancer management","volume":"249","author":"Luo","year":"2020","journal-title":"Carbohydr. Polym."},{"issue":"9","key":"10.1016\/j.biomaterials.2023.122232_bib14","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1111\/j.1478-3231.2008.01745.x","article-title":"All-trans-retinoic acid ameliorates carbon tetrachloride-induced liver fibrosis in mice through modulating cytokine production","volume":"28","author":"Hisamori","year":"2008","journal-title":"Liver Int."},{"issue":"1","key":"10.1016\/j.biomaterials.2023.122232_bib15","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.bbadis.2006.08.009","article-title":"Effects of retinoic acid on the development of liver fibrosis produced by carbon tetrachloride in mice","volume":"1772","author":"Wang","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"issue":"8","key":"10.1016\/j.biomaterials.2023.122232_bib16","doi-asserted-by":"crossref","first-page":"9386","DOI":"10.1021\/acsnano.9b04166","article-title":"Chondroitin sulfate-linked prodrug nanoparticles target the Golgi apparatus for cancer metastasis treatment","volume":"13","author":"Li","year":"2019","journal-title":"ACS Nano"},{"issue":"4","key":"10.1016\/j.biomaterials.2023.122232_bib17","doi-asserted-by":"crossref","first-page":"3910","DOI":"10.1021\/acsnano.8b06924","article-title":"Golgi apparatus-targeted chondroitin-modified nanomicelles suppress hepatic stellate cell activation for the management of liver fibrosis","volume":"13","author":"Luo","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2023.122232_bib18","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.actbio.2022.05.014","article-title":"Chondroitin sulfate-based prodrug nanoparticles enhance photodynamic immunotherapy via Golgi apparatus targeting","volume":"146","author":"Li","year":"2022","journal-title":"Acta Biomater."},{"issue":"3","key":"10.1016\/j.biomaterials.2023.122232_bib19","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.jhep.2014.06.010","article-title":"Inhibition of fibronectin deposition improves experimental liver fibrosis","volume":"62","author":"Altrock","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biomaterials.2023.122232_bib20","doi-asserted-by":"crossref","first-page":"7984","DOI":"10.1038\/ncomms8984","article-title":"MRI detection of breast cancer micrometastases with a fibronectin-targeting contrast agent","volume":"6","author":"Zhou","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2023.122232_bib21","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.biomaterials.2015.11.061","article-title":"Fibrin-targeting peptide CREKA-conjugated multi-walled carbon nanotubes for self-amplified photothermal therapy of tumor","volume":"79","author":"Zhang","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2023.122232_bib22","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jconrel.2020.01.017","article-title":"Targeted delivery of celastrol to renal interstitial myofibroblasts using fibronectin-binding liposomes attenuates renal fibrosis and reduces systemic toxicity","volume":"320","author":"Li","year":"2020","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2023.122232_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2021.117964","article-title":"Co-encapsulation of collagenase type I and silibinin in chondroitin sulfate coated multilayered nanoparticles for targeted treatment of liver fibrosis","volume":"263","author":"Luo","year":"2021","journal-title":"Carbohydr. Polym."},{"issue":"4","key":"10.1016\/j.biomaterials.2023.122232_bib24","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.apsb.2019.07.003","article-title":"Targeted delivery of hyaluronic acid nanomicelles to hepatic stellate cells in hepatic fibrosis rats","volume":"10","author":"Li","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.biomaterials.2023.122232_bib25","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jconrel.2019.04.022","article-title":"An integrin-based nanoparticle that targets activated hepatic stellate cells and alleviates liver fibrosis","volume":"303","author":"Li","year":"2019","journal-title":"J. Contr. Release"},{"issue":"2","key":"10.1016\/j.biomaterials.2023.122232_bib26","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/nprot.2015.017","article-title":"High-yield and high-purity isolation of hepatic stellate cells from normal and fibrotic mouse livers","volume":"10","author":"Mederacke","year":"2015","journal-title":"Nat. Protoc."},{"issue":"1","key":"10.1016\/j.biomaterials.2023.122232_bib27","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/s41563-019-0462-9","article-title":"Hyaluronic acid-bilirubin nanomedicine for targeted modulation of dysregulated intestinal barrier, microbiome and immune responses in colitis","volume":"19","author":"Lee","year":"2020","journal-title":"Nat. Mater."},{"key":"10.1016\/j.biomaterials.2023.122232_bib28","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.biomaterials.2015.08.035","article-title":"Tumor-specific penetrating peptides-functionalized hyaluronic acid-d-\u03b1-tocopheryl succinate based nanoparticles for multi-task delivery to invasive cancers","volume":"71","author":"Liang","year":"2015","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.biomaterials.2023.122232_bib29","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1002\/hep.31418","article-title":"Sirt6 alleviated liver fibrosis by deacetylating conserved lysine 54 on Smad2 in hepatic stellate cells","volume":"73","author":"Zhang","year":"2021","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.biomaterials.2023.122232_bib30","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201203","article-title":"Feeding-induced hepatokine, Manf, ameliorates diet-induced obesity by promoting adipose browning via p38 MAPK pathway","volume":"218","author":"Wu","year":"2021","journal-title":"J. Exp. Med."},{"issue":"10","key":"10.1016\/j.biomaterials.2023.122232_bib31","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.202106115","article-title":"GOLPH3 and GOLPH3L are broad-spectrum COPI adaptors for sorting into intra-Golgi transport vesicles","volume":"220","author":"Welch","year":"2021","journal-title":"J. Cell Biol."},{"issue":"8","key":"10.1016\/j.biomaterials.2023.122232_bib32","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2020107238","article-title":"Golgi maturation-dependent glycoenzyme recycling controls glycosphingolipid biosynthesis and cell growth via GOLPH3","volume":"40","author":"Rizzo","year":"2021","journal-title":"EMBO J."},{"key":"10.1016\/j.biomaterials.2023.122232_bib33","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.matbio.2018.04.006","article-title":"Liver fibrosis: direct antifibrotic agents and targeted therapies","volume":"68\u201369","author":"Schuppan","year":"2018","journal-title":"Matrix Biol."},{"issue":"10","key":"10.1016\/j.biomaterials.2023.122232_bib34","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1007\/s10620-017-4684-x","article-title":"Liver transplantation for nonalcoholic steatohepatitis in the US: temporal trends and outcomes","volume":"62","author":"Cholankeril","year":"2017","journal-title":"Dig. Dis. Sci."},{"issue":"7","key":"10.1016\/j.biomaterials.2023.122232_bib35","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1053\/j.gastro.2019.11.311","article-title":"Mechanisms of fibrosis development in nonalcoholic steatohepatitis","volume":"158","author":"Schwabe","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biomaterials.2023.122232_bib36","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jconrel.2018.05.032","article-title":"Vitamin A-decorated biocompatible micelles for chemogene therapy of liver fibrosis","volume":"283","author":"Qiao","year":"2018","journal-title":"J. Contr. Release"},{"issue":"12","key":"10.1016\/j.biomaterials.2023.122232_bib37","doi-asserted-by":"crossref","first-page":"20739","DOI":"10.1021\/acsnano.2c07796","article-title":"Reactive oxygen species-responsive polypeptide drug delivery system targeted activated hepatic stellate cells to ameliorate liver fibrosis","volume":"16","author":"Hao","year":"2022","journal-title":"ACS Nano"},{"issue":"2","key":"10.1016\/j.biomaterials.2023.122232_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101530","article-title":"The interplay of fibroblasts, the extracellular matrix, and inflammation in scar formation","volume":"298","author":"Moretti","year":"2022","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.biomaterials.2023.122232_bib39","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1053\/j.gastro.2019.07.036","article-title":"ECM1 prevents activation of transforming growth factor \u03b2, hepatic stellate cells, and fibrogenesis in mice","volume":"157","author":"Fan","year":"2019","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.biomaterials.2023.122232_bib40","doi-asserted-by":"crossref","first-page":"821","DOI":"10.33549\/physiolres.934755","article-title":"Hepatic stellate cell: a double-edged sword in the liver","volume":"70","author":"Luo","year":"2021","journal-title":"Physiol. Res."},{"key":"10.1016\/j.biomaterials.2023.122232_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113869","article-title":"Pathophysiological communication between hepatocytes and non-parenchymal cells in liver injury from NAFLD to liver fibrosis","volume":"176","author":"Kumar","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2023.122232_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113888","article-title":"Therapeutic targets, novel drugs, and delivery systems for diabetes associated NAFLD and liver fibrosis","volume":"176","author":"Kumar","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1 Suppl","key":"10.1016\/j.biomaterials.2023.122232_bib43","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/j.jhep.2015.02.039","article-title":"Hepatic fibrosis: concept to treatment","volume":"62","author":"Trautwein","year":"2015","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.biomaterials.2023.122232_bib44","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1053\/j.gastro.2017.12.022","article-title":"Hedgehog-YAP signaling pathway regulates glutaminolysis to control activation of hepatic stellate cells","volume":"154","author":"Du","year":"2018","journal-title":"Gastroenterology"},{"issue":"25","key":"10.1016\/j.biomaterials.2023.122232_bib45","doi-asserted-by":"crossref","first-page":"7537","DOI":"10.7150\/thno.38913","article-title":"The use of micelles to deliver potential hedgehog pathway inhibitor for the treatment of liver fibrosis","volume":"9","author":"Kumar","year":"2019","journal-title":"Theranostics"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961223002405?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961223002405?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T17:21:29Z","timestamp":1758907289000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961223002405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":45,"alternative-id":["S0142961223002405"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2023.122232","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dually fibronectin\/CD44-mediated nanoparticles targeted disrupt the Golgi apparatus and inhibit the hedgehog signaling in activated hepatic stellate cells to alleviate liver fibrosis","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2023.122232","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"122232"}}